For retatrutide , the 2023 New England Journal of Medicine phase 2 trial used doses of up to 12 mg weekly, with a structured escalation schedule beginning at lower doses and increasing incrementally over a period of weeks
European Union 13.4
Lavoie S, Murray MM, Deppen P, Knyazeva MG, Berk M, Boulat O, Bovet P, Bush AI, Conus P, Copolov D, Fornari E, Meuli R, Solida A, Vianin P, Cunod M, Buclin T, Do KQ:Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients
At this level, 100mg provides 50 doses, enough for about 7 weeks of daily administration
K., Sapra, L
Results are often noticeable immediately after the session, with benefits lasting up to a week or more, depending on the individual and the type of Therapy received